期刊
MABS
卷 5, 期 1, 页码 80-85出版社
LANDES BIOSCIENCE
DOI: 10.4161/mabs.22593
关键词
vNAR; IgNAR; single domain antibodies; rhTNF alpha; shark; neutralization; Heterodontus francisci
资金
- SILANES S.A. de C.V.
- CONACYT
The therapeutic use of single domain antibodies (sdAbs) is a promising new approach because these small antibodies maintain antigen recognition and neutralization capacity, have thermal and chemical stability and have good solubility. In this study, using phage display technology, we isolated a variable domain of a IgNAR (vNAR) from a Heterodontus francisci shark immunized against the recombinant human cytokine TNF alpha (rhTNF alpha). One clone T43, which expresses the vNAR protein in the periplasmic space, was isolated from the fourth round of panning. T43 had the capacity to recognize rhTNF and neutralize it in vitro, indicating that T43 has potential as a therapeutic that can be used for diseases in which this pro-inflammatory cytokine needs to be controlled.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据